Drug affordability
The EU evaluates affordability and availability of medicines

Drug prices are rising across the European Union, and in economically-difficult times this is having an impact on drug affordability and accessibility. The European Union health ministers have met to discuss the impact of the situation, and make decisions that could change the way that drugs are priced across the region. These conclusions were published […]

Speeding drugs to market using adaptive pathways

For parents of children with serious disorders where there is no approved treatment, or physicians who have tried everything for their patients with terminal diseases, the wait for approval of innovative drugs is a long one. The European Medicines Agency’s adaptive pathways pilot project aims to allow patients and their physicians to access life-changing or […]

Accelerate market access
Regulatory initiatives to accelerate market access – UK, Japan and USA edition

Accelerated pathways are emerging in individual countries that are designed to speed therapies through the approvals process and onto the market for patients who have unmet needs. Following on from our EU focus, in this post we look at the key schemes to date, that are in place in the UK, Japan and USA to […]

Valid Insight
The impact of austerity on global pharma pricing and access

Austerity has been the buzzword for governments around the globe, as economies fight deficits and economic downturns. The combination of austerity, along with the aging population and the rising cost of therapeutics, means that healthcare is one of the areas particularly hit by the financial challenges. In order to ensure that the right patients can […]

High-cost therapeutics
Funding challenges of super-high-cost therapeutics

Since the completion of the human genome project in 2003, researchers at the 1000 Genomes Project have sequenced over 2500 human genomes from 26 groups of people around the world; the genome of a human from around 430,000 years ago has been sequenced; and the UK plans to sequence 100,000 human genomes from NHS patients. […]